A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study.
AIMS: Insulin is normally added to oral glucose-lowering drugs in people with type 2 diabetes when glycaemic control becomes suboptimal. We evaluated outcomes in people starting insulin therapy with neutral protamine Hagedorn (NPH), detemir, glargine or p.....